AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$612M
This Quarter Return
+1.8%
1 Year Return
+36.74%
3 Year Return
+173.74%
5 Year Return
+333.08%
10 Year Return
+727.51%
AUM
$522M
AUM Growth
-$52.3M
(-9.1%)
Cap. Flow
-$50.1M
Cap. Flow
% of AUM
-9.6%
Top 10 Holdings %
Top 10 Hldgs %
40.58%
Holding
177
New
52
Increased
37
Reduced
30
Closed
43
Top Buys
| 1 |
AbbVie
ABBV
|
$19.6M |
| 2 |
Macerich
MAC
|
$13M |
| 3 |
EVA
Enviva Inc.
EVA
|
$9.41M |
| 4 |
Okta
OKTA
|
$7.47M |
| 5 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
$7.37M |
Top Sells
| 1 |
Rithm Capital
RITM
|
$19.4M |
| 2 |
Zimmer Biomet
ZBH
|
$12.9M |
| 3 |
Oracle
ORCL
|
$12.8M |
| 4 |
United Rentals
URI
|
$10.4M |
| 5 |
PE
PARSLEY ENERGY INC
PE
|
$10.3M |
Sector Composition
| 1 | Healthcare | 24.92% |
| 2 | Technology | 16.92% |
| 3 | Utilities | 10.18% |
| 4 | Materials | 7.8% |
| 5 | Energy | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$661B
| $634K | 0.08% |
+7,500
| New | +$634K |
|
|
ORBC
77
DELISTED
ORBCOMM, Inc.
ORBC
| $611K | 0.07% |
+60,000
| New | +$611K |
|
78
Supernus Pharmaceuticals
SUPN
$2.52B
| $598K | 0.07% |
+15,000
| New | +$598K |
|
79
Universal Health Services
UHS
$11.6B
| $567K | 0.07% |
+5,000
| New | +$567K |
|
80
CVS Health
CVS
$93B
| $545K | 0.07% |
+7,500
| New | +$545K |
|
81
Boston Scientific
BSX
$159B
| $496K | 0.06% |
+20,000
| New | +$496K |
|
|
BOLD
82
DELISTED
Audentes Therapeutics, Inc
BOLD
| $471K | 0.06% |
15,072
-10,000
| -40% | -$313K |
|
83
McKesson
MCK
$85.9B
| $468K | 0.06% |
+3,000
| New | +$468K |
|
|
MULE
84
DELISTED
MuleSoft, Inc.
MULE
| $465K | 0.06% |
+20,000
| New | +$465K |
|
85
Voyager Therapeutics
VYGR
$204M
| $415K | 0.05% |
+25,000
| New | +$415K |
|
86
Advanced Micro Devices
AMD
$263B
| $411K | 0.05% |
40,000
+30,000
| +300% | +$308K |
|
87
Medtronic
MDT
$118B
| $404K | 0.05% |
+5,000
| New | +$404K |
|
|
MLNX
88
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $388K | 0.05% |
+6,000
| New | +$388K |
|
89
Exelixis
EXEL
$9.95B
| $380K | 0.05% |
+12,500
| New | +$380K |
|
90
Vertex Pharmaceuticals
VRTX
$102B
| $375K | 0.05% |
2,500
-16,000
| -86% | -$2.4M |
|
|
WBA
91
DELISTED
Walgreens Boots Alliance
WBA
| $363K | 0.04% |
+5,000
| New | +$363K |
|
92
Adverum Biotechnologies
ADVM
$68.2M
| $350K | 0.04% |
+10,000
| New | +$350K |
|
93
8x8 Inc
EGHT
$270M
| $338K | 0.04% |
24,000
-6,000
| -20% | -$84.5K |
|
94
Regenxbio
RGNX
$498M
| $334K | 0.04% |
10,000
| – | – |
|
|
NBIS
95
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $328K | 0.04% |
10,000
-20,000
| -67% | -$656K |
|
|
PTE
96
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $327K | 0.04% |
+564
| New | +$327K |
|
97
AtriCure
ATRC
$1.73B
| $319K | 0.04% |
17,500
+2,500
| +17% | +$45.6K |
|
98
Atlassian
TEAM
$44.8B
| $319K | 0.04% |
7,000
-12,000
| -63% | -$547K |
|
99
Aldeyra Therapeutics
ALDX
$350M
| $306K | 0.04% |
45,000
+5,448
| +14% | +$37K |
|
|
CY
100
DELISTED
Cypress Semiconductor
CY
| $305K | 0.04% |
+20,000
| New | +$305K |
|